12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Deals

chemagen Biopolymer-Technologie AG, PerkinElmer deal

PerkinElmer acquired chemagen for an undisclosed sum. PerkinElmer gains chemagen's nucleic acid isolation technology and...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >